SCHEMBL20168784

SCHEMBL20168784

CC(c1cnc(-c2ccccc2F)[nH]1)n1cc(-c2ccc3c(c2)OCCN3)c2c(N)ncnc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
PRKDC P78527 2/20 0.38
KDR P35968 11/20 0.38
TEK Q02763 6/20 0.38
LCK P06239 4/20 0.38
SRC P12931 4/20 0.38
BTK Q06187 2/20 0.37
RET P07949 4/20 0.37
ABL1 P00519 1/20 0.35
EGFR P00533 1/20 0.35
HCK P08631 1/20 0.35
MTOR P42345 1/20 0.35
EPHB4 P54760 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
RIPK2 O43353 1/20 0.35
GRM2 Q14416 1/20 0.34
ALOX5AP P20292 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20175825 0.87 NSD2 (0.38) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30037531 0.83 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20162933 0.83 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23481446 0.83 PIK3CD (0.40) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20175828 0.81 KDR (0.47) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20162746 0.80 KDR (0.44) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30037110 0.80 KDR (0.44) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20175297 0.79 KDR (0.42) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20175829 0.79 KDR (0.43) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL27208128 0.79 KDR (0.40) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541390-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS Cystic Fibrosis Foundation Therapeutics Inc. (US) 2019-09-25 EP disclosed
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed